Company Profile
ART Advanced Research Technologies Inc. (ART) researches, designs, develops and markets optical imaging products for the medical and pharmaceutical industries. ART has developed several products that relate to medical imaging, medical diagnostics, medical research and drug discovery.
Optix is an in vivo optical molecular imaging device designed to monitor physiological changes in small animals during preclinical drug studies. Industry and academic leaders worldwide use Optix to bring new and better treatments to patients faster.
SoftScan is an optical breast imaging device designed to improve the diagnosis and treatment of breast cancer. Marketed under the name SoftScan, it uses ART’s unique molecular imaging technology to display and discriminate between normal and malignant tissue.
The Fenestra line of molecular imaging contrast products provide image enhancement for a wide range of preclinical microCT applications. For instance, it allows scientists to see greater detail in their imaging studies. It also has potential for other major imaging applications.
Vision
... to harness the power of optical molecular imaging to accelerate the delivery of better therapies and cures.
Mission
... to lead the development and sales of optical molecular imaging systems for the medical and pharmaceutical sectors.
Values
... to demonstrate respect, integrity, creativity and responsiveness towards its employees, customers, partners, and key stakeholders.
Management Philosophy
... to foster an open-minded, inclusive and team-oriented working environment that promotes employee development and personal leadership towards the achievement of results.
Partnering Philosophy
... to build relationships with strategic partners that are based on mutual trust and respect.
... to maintain technological leadership, competitive advantage and access to global markets by partnering with world-class scientific, medical and business leaders.